AliveCor Inc. is a global innovator and pioneer in transforming cardiac care using mobile technology. Based in California, USA, it is a global leader in AI-based compact ECG technology for point of care testing & remote patient monitoring. AliveCor's KardiaMobile & KardiaMobile 6L are US-FDA cleared to detect common arrhythmias like Atrial Fibrillation in just 30 seconds. These devices are medically validated & carry the confidence of over 170 + publications in peer-reviewed journals. KardiaMobile & Kardiamobile 6L are recommended by leading cardiologists & used by patients worldwide for accurate ECG recordings. KardiaMobile 6L is the world's first and only US FDA cleared 6 lead personal ECG device that provides a 6x better view of the heart. It provides multiple AI based automated ECG determinations including possible atrial fibrillation. The National Institute for Health & Care Excellence (NICE), UK recommends KardiaMobile 6L as a cost-effective way to detect Atrial Fibrillation.